Skip to main content
Genomictree Inc. logo

Genomictree Inc. — Investor Relations & Filings

Ticker · 228760 ISIN · KR7228760005 KO Professional, scientific and technical activities
Open in API
Filings indexed 237 across all filing types
Latest filing 2018-11-13 Investor Presentation
Country KR South Korea
Listing KO 228760

About Genomictree Inc.

https://genomictree.com/eng/

Genomictree Inc. is a molecular diagnostics company that develops and commercializes products for the early detection and diagnosis of cancer. The company specializes in epigenomics, utilizing its proprietary genomic-scale discovery tools to identify DNA methylation biomarkers. Its flagship product line, EarlyTect®, offers non-invasive tests for the early screening of colorectal, lung, and bladder cancers. Additionally, Genomictree provides AccuraTect™, a companion diagnostic test for cancer. The company's mission is to improve patient quality of life and reduce medical costs through accessible and accurate early-stage cancer detection.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최결과
Investor Presentation Classification · 95% confidence The document is a short, structured notification regarding the results of an Investor Relations (IR) meeting held by Genomictree. It lists the date, location, attendees, and agenda items of the meeting, and provides a link to where the actual IR materials are posted. Per the 'Menu vs Meal' rule, since this is a short announcement of an event and refers to the availability of materials elsewhere rather than being the presentation itself, it is classified as a Regulatory Filing (RNS) as it serves as a formal disclosure of corporate activity.
2018-11-13 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) meeting. It specifies the date, time, location, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2018-11-09 Korean
기타주요경영사항(자율공시)
Regulatory Filings Classification · 95% confidence The document is a short regulatory disclosure (577 characters) from the company 'Genomictree' regarding the filing of a preliminary review application for KOSDAQ listing. It does not constitute a full financial report or a specific event like a dividend or director dealing. As it is a general regulatory announcement regarding corporate actions that does not fit into the other specific categories, it is classified as a Regulatory Filing (RNS).
2018-11-01 Korean
이전상장결정
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from the company 'Genomictree' regarding a decision to transfer its stock listing to the KOSDAQ market. It details the board resolution date, the reasons for the transfer, and the current share distribution. Since this is a specific regulatory announcement regarding a change in listing status and does not fit into categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2018-10-31 Korean
기타주요경영사항(자율공시)(기술평가 결과)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the company 'Genomictree' regarding the results of a technical evaluation for their diagnostic technologies. It is titled 'Other Major Management Matters (Voluntary Disclosure)' and provides specific details on the evaluation agencies, grades, and future plans regarding a KOSDAQ listing. Since it is a formal regulatory disclosure of a specific corporate event that does not fit into financial reporting or specific shareholder meeting categories, it is classified as a Regulatory Filing (RNS).
2018-10-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used to disclose insider shareholdings and changes in ownership by company executives. This falls under the 'Director's Dealing' category as it reports personal share transactions and ownership changes by an executive (Yoon Dae-Kyoung).
2018-10-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.